Eric Snyder is a seasoned professional in the venture investments sector, currently serving as a Partner and Principal at Novo Holdings since March 2018. In addition to tenure at Novo, Eric holds multiple board positions across various companies, including Magenta Medical Ltd., Octave, FIRE1, and Nalu Medical, Inc. with roles ranging from Member of the Board of Directors to Observer. Eric has previously contributed to the boards of Disc Medicine, Deep 6 AI, and F2G, among others. Eric's academic credentials include a PhD in Neuroscience from Brown University and a recent certification in Leading Digital Transformation in Health Care from Harvard Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices